HEPATITIS B VACCINE composed of chemically inactivated() particles obtained from the plasma of healthy chronic HBsAg carriers by , separated from () the infectious Dane particle by (), and absorbed on ()
hepatitis B surface antigen (HBsAg), plasmapheresis, density gradient centrifugation, aluminum hydroxide
